PRL and breast cancer: It has also been reported that PRL can increase the viability and decrease the apoptosis of human luminal-A BC cell lines by activating survival pathways involving enzymes such as metalloproteinase carboxypeptidase-D and EDD E3 ubiquitin ligase and the protein Ki-67 (18–21, 47).